Latest Conference Articles

Although there are some advantages and disadvantages to both routes of antibiotic administration, several factors must be considered when determining the best antibiotic delivery method for the patient, including cost, effort of administration, and safety risks.

Abaloparatide and teriparatide are the only anabolic agents approved by the FDA for women with osteoporosis at high-risk of fragility fractures.

In this video, David Hager, PharmD, BCPS, the director of clinical pharmacy services at UW Health, Madison, WI, discusses the relationship between burnout and depression.

In this clip, pharmacy student Timothy Archibald discusses his poster presentation on Firvanq.

In this clip, pharmacy student George Haddad discusses his poster presentation on Orbactiv.

Health system and hospital pharmacies could see more opportunities for revenue recovery for health system and hospital pharmacies in 2019, as well as increased transparency and access to care for patients.

In a 2-part study, a research team with Desert Regional Medical Center in Corona, CA is analyzing the need for pharmacist intervention for patients with HIV.

Each year, the Institute for Safe Medication Practices (ISMP) releases its review of the year's most common medication safety issues.

Getting involved in advocacy efforts is key to showing the value of the pharmacy profession.

In this clip, Jon Edwards, a director of marketing for Baxter, discusses the company's "Stand and Deliver" campaign.

Pharmacists must remain educated about errors and ways to prevent them, according to the Institute for Safe Medication Practices.

What if there was a drug delivery system intuitive enough to respond to changes in a patient’s disease?

Cheyenne Newsome, PharmD, PhC, BCACP, clinical assistant professor at the Washington State University College of Pharmacy, discusses the health disparities seen in the LGBTQ community and what considerations providers should keep in mind when treating transgender patients.

The annual forecast predicts developments in different areas that are likely to challenge pharmacy practice leaders in hospitals and health systems in the future.

Michael Ganio, PharmD, MS, BCPS, FASHP, ASHP Director of Pharmacy Practice and Quality, talks about biosimilar use and factors influencing uptake in the United States.

In this clip, Athar Mirza, a senior director of marketing for Baxter, discusses the company's Stand and Deliver campaign.

As technological innovations continue to transform health care, many pharmacists and other providers are increasingly looking to digital solutions for improving medication adherence among their patients.

As biosimilar development continues to grow, pharmacists will be essential in transitioning both clinicians and patients alike in the use of these therapies.

In a Tuesday session at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Anaheim, CA, some predictions were shared from the ASHP Foundation’s Pharmacy Forecast.

Although smart pump alerts can be an useful tool in maintaining patient safety, it is important for health systems to take a collaborative and data-driven approach to reducing unnecessary alerts.

In this clip, Erin McCreary, PharmD, BCPS, an antimicrobial stewardship/infectious disease clinical pharmacist at the University of Pittsburgh Medical Center, reflects on her experience of returning to Anaheim for ASHP Midyear 4 years after doing so as a student.

Christopher Topoleski, who is the Director of Federal Legislative Affairs for ASHP, discusses the ongoing legislative efforts targeting drug prices and what to expect moving forward.

Mark Eastham, BS, RPh, Senior Vice President of McKesson RxO, discusses the growth of specialty pharmacy in the health system space.

As smart infusion technology is increasingly used by pharmacists in health-system settings, analyzing data from these devices can prove key to improving patient health.

The American Society of Health-System Pharmacists (ASHP) recognized its Donald Francke Medal recipient and other award winners at the 2018 ASHP Midyear Clinical Meeting in Anaheim, CA.

At the 2018 ASHP Midyear Clinical Meeting and Exhibition, Ashley Mains Espinosa, PharmD, Director of System Pharmacy Business Services at SCL Health, offered advice on how pharmacy providers can work to overcome biosimilar reimbursement challenges and encourage biosimilar adoption.

In this clip, Christopher Topoleski, Director of Federal Legislative Affairs for the American Society of Health-System Pharmacists (ASHP), talks about how the legislative landscape of the 340B Drug Pricing Program has evolved and what's to come.